The Effects of Cholestasis and Cirrhosis on Gastric Acid and Pepsin Secretions in Rat: Involvement of Nitric Oxide

Publish Year: 1389
نوع سند: مقاله ژورنالی
زبان: English
View: 171

This Paper With 6 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-13-4_008

تاریخ نمایه سازی: 3 آبان 1400

Abstract:

Objective(s) The liver has major role in the organism homeostasis, interactions with other systems, synthesis and metabolism of bile production, drug detoxification and hormone inactivation. Cholestasis can be defined as an impairment of the bile flow which can lead to hepatocytes necrosis and finally cirrhosis. Some studies reported a gastric acid secretion reduction in cirrhotic subjects, while others reported normal production gastric acid secretion. Our aim was to evaluate the effects of cholestasis and cirrhosis on gastric acid and pepsin secretions and its possible mechanism in rat. Materials and Methods Male Wistar rats were randomly divided into five groups (n= ۸): control, cholestasis, sham cholestasis, cirrhosis and sham cirrhosis. Laparatomy was done under general anesthesia and then bile duct ligation (BDL) was performed. After ۲ and ۴ weeks in cholestasis and cirrhosis groups respectively, gastric content was collected by wash-out technique. Basal and stimulated acid and pepsin secretions were measured by using titration and the Anson method respectively in all groups. In order to measure stimulated acid and pepsin secretions, pentagastrin (۲۵ pg/kg, i.p.) was used. Nitric Oxide (NO) metabolites of gastric tissue were determined by Griess microassy method. Results Acid and pepsin secretions were significantly reduced in cholestatic and cirrhotic rats in comparison with control and sham groups (P< ۰.۰۱). NO metabolite of gastric tissue was significantly increased in cholestatic and cirrhotic rats (P< ۰.۰۱). Conclusion Reducing of gastric acid and pepsin output in cholestatic and cirrhotic rats may be due to increasing in NO content of gastric tissue.

Authors

Fatemeh Nabavizadeh

Department of Physiology, Tehran University of Medical Sciences, Tehran, Iran

Rohallah Moloudi

Department of Physiology, Tehran University of Medical Sciences, Tehran, Iran

Ahmad Reza Dehpour

Department of Physiology, Tehran University of Medical Sciences, Tehran, Iran

Hossein Nahrevanian

Pasteur Institute of Iran, Tehran, Iran

Kaveh Shahvaisi

Department of Physiology, Tehran University of Medical Sciences, Tehran, Iran

Ehsan Salimi

Tehran University of Medical Sciences, Tehran, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • ۱.Gaskari SA, Honar H, Lee SS. Therapy insight: cirrhotic cardiomyopathy. ...
  • ۲.Paumgartner G. Medical treatment of cholestatic liver diseases: From pathobiology ...
  • ۳.Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: ...
  • ۴.Wong F. Cirrhotic cardiomyopathy. Hepatol Int ۲۰۰۹; ۳:۲۹۴-۳۰۴ ...
  • ۵.Avila FT, Avila FS, de-Sicilia MS, Chavez-Tapia NC, et al. ...
  • ۶.Mesejo A, Juan YM, Serrano A. Liver cirrhosis and encephalopathy: ...
  • ۷.Castilla-Cortazar I, Pascual M, Urdaneta E, Pardo J, Puche JE, ...
  • ۸.Conchillo M, Prieto J, Quiroga J. Insulin-like growth factor I ...
  • ۹.Wang X, Zhong YX, Zhang ZY, Lu J, Lan M, ...
  • ۱۰.Schiedermaier P, Harrison P, Arthur M, Grandt D, Sutton R, ...
  • ۱۱.Konturek SJ, Gonciarz M, Bielanski W, Mazur W, Mularczyk A, ...
  • ۱۲.Lodato F, Azzaroli F, Di Girolamo M, Feletti V, Cecinato ...
  • ۱۳.Konturek SJ, Gonciarz M, Gonciarz Z, Bielanski W, Mazur W, ...
  • ۱۴.Kitano S, Dolgor B .Does portal hypertension contribute to the ...
  • ۱۵.Cortez-pinto H, Ferra MA, Baptista A, Demoura MC, De Moura ...
  • ۱۶.Yeh JL , Peng YC , Tung CF , Chen ...
  • ۱۷.Nahavandi A, Dehpour AR, Mani AR, Homayounfar H, Abdoli A, ...
  • ۱۸.Nabavizadeh F , Zahedi Asl S , Garib Naseri MK, ...
  • ۱۹.Nabavizadeh F, Salimi E, Sadroleslami Z, Vahedian J. Saffron (Crocus ...
  • ۲۰.Nahrevanian H, Gholizadeh J, Farahmand M, Assmar M, Sharifi K, ...
  • ۲۱.Zullo A, Romiti A, Rinaldi V, Vecchione A, Hassan C, ...
  • Celinski K, Konturek PC, Slomka M, Cichoz-Lach H, Gonciarz M, ...
  • Izbeki F,Kiss I, Wittmann T, Varkonyi T, Varkonyi TT, Legrady ...
  • ۲۴.Nam YJ, Kim SJ, Shin WC, Lee JH, Choi WC, ...
  • ۲۵.Kamalaporn P, Sobhonslidsuk A, Jatchavala J, Atisook K, Rattanasiri S, ...
  • ۲۶.Konturek SJ, Gonciarz M, Gonciarz Z, Bielanski W, Mazur W, ...
  • ۲۷.Dijkstra G, Van GH, Jansen PL, Moshage Hl. Targeting nitric ...
  • Holm M, Powell T, Casselbrant A, Johansson B, Fa'ndriks L. ...
  • ۳۰.Nylander O, Ha'llgren A, Sababi M. COX inhibition excites enteric ...
  • ۳۱.Hasebe K, Horie S, Komasaka M, Yano S, Watanabe K. ...
  • ۳۲.Hasebe K, Horie S, Noji T, Watanabe K, Yano S. ...
  • نمایش کامل مراجع